Vanderbilt Center For Technology Transfer And Commercialization

Vanderbilt tech transfer sets records: $86.7M in licensing revenue in FY22 ranks sixth-highest nationally, and $96M in licensing revenue in FY23 is largest in university history. Revamped processes in the Center for Technology Transfer and Commercialization makes licensing and launching new ventures faster and easier than ever before. Read More

With the new partnership, LaunchTN and Vanderbilt will work collaboratively to support, engage and attract high-growth startups. Read More

Vanderbilt University has signed an exclusive worldwide license and research collaboration agreement with Neumora Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Read More

Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read More

To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time. Read More

Vanderbilt University is ranked 36th in a 2019 U.S. patents report released by the by the National Academy of Inventors and the Intellectual Property Owners Association. Read More